{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:34:34Z","timestamp":1790321674753,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,11,23]],"date-time":"2014-11-23T00:00:00Z","timestamp":1416700800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2407-14-866","type":"journal-article","created":{"date-parts":[[2014,11,23]],"date-time":"2014-11-23T02:01:29Z","timestamp":1416708089000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Inhibition of STAT3-interacting protein 1 (STATIP1) promotes STAT3 transcriptional up-regulation and imatinib mesylate resistance in the chronic myeloid leukemia"],"prefix":"10.1186","volume":"14","author":[{"given":"Andr\u00e9 L","family":"Mencalha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephany","family":"Corr\u00eaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Salles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1rbara","family":"Du Rocher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo F","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana","family":"Abdelhay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,23]]},"reference":[{"key":"5063_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/BF02258360","volume":"5","author":"R Garcia","year":"1998","unstructured":"Garcia R, Jove R: Activation of STAT transcription factors in oncogenic tyrosine kinase signalling. J Biomed Sci. 1998, 5: 79-85. 10.1007\/BF02258360.","journal-title":"J Biomed Sci"},{"key":"5063_CR2","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1128\/MCB.18.5.2545","volume":"18","author":"J Turkson","year":"1998","unstructured":"Turkson J, Bowman T, Garcia R, Caldenhoven E, de Groot RP, Jove R: Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol Cell Biol. 1998, 18: 2545-2552.","journal-title":"Mol Cell Biol"},{"key":"5063_CR3","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.1038\/sj.onc.1206607","volume":"22","author":"P Coppo","year":"2003","unstructured":"Coppo P, Dusanter-Fourt I, Millot G, Nogueira MM, Dugray A, Bonnet ML, Mitjavila-Garcia MT, Le Pesteur D, Guilhot F, Vainchenker W, Sainteny F, Turhan AG: Constitutive and specific activation of STAT3 by BCR-ABL in embryonic stem cells. Oncogene. 2003, 22: 4102-4110. 10.1038\/sj.onc.1206607.","journal-title":"Oncogene"},{"key":"5063_CR4","first-page":"2948","volume":"63","author":"V Sriuranpong","year":"2003","unstructured":"Sriuranpong V, Park JI, Amornphimoltham P, Patel V, Nelkin BD, Gutkind JS: Epidermal growth factor receptor-independent constitutive activation of STAT3 in head and neck squamous cell carcinoma is mediated by the autocrine\/paracrine stimulation of the Interleukin 6\/gp130 cytokine system. Cancer Res. 2003, 63: 2948-2956.","journal-title":"Cancer Res"},{"key":"5063_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1365-2141.2006.06161.x","volume":"134","author":"P Coppo","year":"2006","unstructured":"Coppo P, Flamant S, De Mas V, Jarrier P, Guillier M, Bonnet ML, Lacout C, Guilhot F, Vainchenker W, Turhan AG: BCR-ABL activates STAT3 via JAK end MEK pathways in human cells. Br J Haematol. 2006, 134: 171-179. 10.1111\/j.1365-2141.2006.06161.x.","journal-title":"Br J Haematol"},{"key":"5063_CR6","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1242\/jcs.00963","volume":"117","author":"JS Rawlings","year":"2004","unstructured":"Rawlings JS, Rosler KM, Harrison DA: The JAK\/STAT signaling pathway. J Cell Sci. 2004, 117: 1281-1283. 10.1242\/jcs.00963.","journal-title":"J Cell Sci"},{"key":"5063_CR7","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1038\/sj.onc.1203476","volume":"19","author":"J Bromberg","year":"2000","unstructured":"Bromberg J, Darnell JE: The role of STATs in transcriptional control and their impact on cellular function. Oncogene. 2000, 19: 2468-2473. 10.1038\/sj.onc.1203476.","journal-title":"Oncogene"},{"key":"5063_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1084\/jem.189.1.63","volume":"189","author":"N Kiuchi","year":"1999","unstructured":"Kiuchi N, Nakajima K, Ichiba M, Fukada T, Narimatsu M, Mizuno K, Hibi M, Hirano T: STAT3 is required for the gp130-mediated full activation of the c-myc gene. J Exp Med. 1999, 189: 63-73. 10.1084\/jem.189.1.63.","journal-title":"J Exp Med"},{"key":"5063_CR9","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1038\/sj.onc.1203551","volume":"20","author":"T Hirano","year":"2000","unstructured":"Hirano T, Ishihara K, Hibi M: Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene. 2000, 20: 2548-2556.","journal-title":"Oncogene"},{"key":"5063_CR10","doi-asserted-by":"publisher","first-page":"14665","DOI":"10.1074\/jbc.M707429200","volume":"283","author":"GZ Cheng","year":"2008","unstructured":"Cheng GZ, Zhang WZ, Sun M, Wang Q, Coppola D, Mansour M, Xu LM, Costanzo C, Cheng JQ, Wang LH: Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function. J Biol Chem. 2008, 283: 14665-14673. 10.1074\/jbc.M707429200.","journal-title":"J Biol Chem"},{"key":"5063_CR11","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/sj.onc.1201490","volume":"16","author":"N Cambier","year":"1998","unstructured":"Cambier N, Chopra R, Strasser A, Metcalf D, Elefanty AG: BCR-ABL activates pathways medianting cytokine independence and protection against apoptosis in murine haematopoietic cells in a dose-dependent manner. Oncogene. 1998, 16: 335-348. 10.1038\/sj.onc.1201490.","journal-title":"Oncogene"},{"key":"5063_CR12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/sj.leu.2403241","volume":"18","author":"LS Steelman","year":"2004","unstructured":"Steelman LS, Pohnert SC, Shelton JG, Franklin RA, Bertrand FE, McCubrey JA: JAK\/STAT, Raf\/MEK\/ERK, PI3K\/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia. 2004, 18: 189-218. 10.1038\/sj.leu.2403241.","journal-title":"Leukemia"},{"key":"5063_CR13","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/leu.2008.26","volume":"22","author":"LS Steelman","year":"2008","unstructured":"Steelman LS, Abrams SL, Whelan J, Bertrand FE, Ludwig DE, B\u00e4secke J, Libra M, Stivala F, Milella M, Tafuri A, Lunghi P, Bonati A, Martelli AM, McCubrey JA: Contributions of the Raf\/MEK\/ERK, PI3K\/PTEN\/Akt\/mTOR and Jak\/STAT pathways to leukemia. Leukemia. 2008, 22: 686-707. 10.1038\/leu.2008.26.","journal-title":"Leukemia"},{"key":"5063_CR14","doi-asserted-by":"publisher","first-page":"6558","DOI":"10.1073\/pnas.84.18.6558","volume":"84","author":"J McLaughlin","year":"1987","unstructured":"McLaughlin J, Chianese E, Witte ON: In vitro transformation of immature hematopoietic cells by the P210 BCR\/ABL oncogene product of the Philadelphia chromosome. Proc Natl Acad Sci U S A. 1987, 84: 6558-6562. 10.1073\/pnas.84.18.6558.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5063_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1034\/j.1600-0609.2001.t01-1-00385.x","volume":"67","author":"K Spiekermann","year":"2001","unstructured":"Spiekermann K, Biethahn S, Wilde S, Hiddemann W, Alves F: Constitutive activation of STAT transcription factors in acute myelogenous leukaemia. Eur J Haematol. 2001, 67: 63-71. 10.1034\/j.1600-0609.2001.t01-1-00385.x.","journal-title":"Eur J Haematol"},{"key":"5063_CR16","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S0301-472X(01)00787-1","volume":"30","author":"K Spiekermann","year":"2002","unstructured":"Spiekermann K, Pau M, Schwab R, Schmieja K, Franzrahe S, Hiddemann W: Constitutive activation of STAT3 and STAT5 is induced by leukemic fusion proteins with protein tyrosine kinase activity and is sufficient for transformation of hematopoietic precursor cells. Exp Hematol. 2002, 30: 262-271. 10.1016\/S0301-472X(01)00787-1.","journal-title":"Exp Hematol"},{"key":"5063_CR17","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1158\/1535-7163.MCT-08-0314","volume":"7","author":"NN Bewry","year":"2008","unstructured":"Bewry NN, Nair RR, Emmons MF, Boulware D, Pinilla-Ibarz J, Hazlehurst LA: STAT3 contributes to resistance toward BCR-ABL inhibitors in a bone marrow microenvironment model of drug resistance. Mol Cancer Ther. 2008, 7: 3169-3175. 10.1158\/1535-7163.MCT-08-0314.","journal-title":"Mol Cancer Ther"},{"key":"5063_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.canlet.2009.07.015","volume":"289","author":"TK Chana","year":"2009","unstructured":"Chana TK, Lia K, Liua SL, Chua KH, Toha M, Xie WD: Cucurbitacin B inhibits STAT3 and the Raf\/MEK\/ERK pathway in leukaemia cell line K562. Cancer Lett. 2009, 289: 46-59.","journal-title":"Cancer Lett"},{"key":"5063_CR19","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.leukres.2009.03.033","volume":"33","author":"HY Jia","year":"2009","unstructured":"Jia HY, Wu JX, Zhu XF, Chen JM, Yang SP, Yan HJ, Tan L, Zeng YX, Huang W: ZD6474 inhibits Src kinase leading to apoptosis of imatinib-resistant K562 cells. Leuk Res. 2009, 33: 1512-1519. 10.1016\/j.leukres.2009.03.033.","journal-title":"Leuk Res"},{"key":"5063_CR20","first-page":"845","volume":"92","author":"L Espert","year":"2005","unstructured":"Espert L, Dusanter-Fourt I, Chelbi-Alix MK: Negative regulation of the JAK\/STAT: pathway implication in tumorigenesis. Bull Cancer. 2005, 92: 845-857.","journal-title":"Bull Cancer"},{"key":"5063_CR21","doi-asserted-by":"publisher","first-page":"8057","DOI":"10.1074\/jbc.271.14.8057","volume":"271","author":"CH Yang","year":"1996","unstructured":"Yang CH, Shi W, Basu L, Murti A, Constantinescu SN, Blatt L, Croze E, Mullersman JE, Pfeffer LM: Direct association of STAT3 with the IFNAR-1 chain of the human type I interferon receptor. J Biol Chem. 1996, 271: 8057-8061. 10.1074\/jbc.271.14.8057.","journal-title":"J Biol Chem"},{"key":"5063_CR22","doi-asserted-by":"publisher","first-page":"6174","DOI":"10.1093\/emboj\/cdf596","volume":"21","author":"K Nakayama","year":"2002","unstructured":"Nakayama K, Kim KW, Miyajima A: A novel nuclear zinc finger protein EZI enhances nuclear retention and transactivation of STAT3. EMBO J. 2002, 21: 6174-6184. 10.1093\/emboj\/cdf596.","journal-title":"EMBO J"},{"key":"5063_CR23","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1093\/intimm\/dxh331","volume":"17","author":"N Sato","year":"2005","unstructured":"Sato N, Kawai T, Sugiyama K, Muromoto R, Imoto S, Sekine Y, Ishida M, Akira S, Matsuda T: Physical and functional interactions between STAT3 and ZIP kinase. Int Immunol. 2005, 17: 1543-1552. 10.1093\/intimm\/dxh331.","journal-title":"Int Immunol"},{"key":"5063_CR24","doi-asserted-by":"publisher","first-page":"7656","DOI":"10.1038\/sj.onc.1210567","volume":"26","author":"C Lufei","year":"2007","unstructured":"Lufei C, Koh TH, Uchida T, Cao X: Pin1 is required for the Ser727 phosphorylation-dependent Stat3 activity. Oncogene. 2007, 26: 7656-7664. 10.1038\/sj.onc.1210567.","journal-title":"Oncogene"},{"key":"5063_CR25","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1042\/bj20030668","volume":"376","author":"T Zhang","year":"2003","unstructured":"Zhang T, Ma J, Cao X: Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling. Biochem J. 2003, 376: 457-464. 10.1042\/BJ20030668.","journal-title":"Biochem J"},{"key":"5063_CR26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/jb\/mvj033","volume":"139","author":"K Yamashina","year":"2006","unstructured":"Yamashina K, Yamamoto H, Chayama K, Nakajima K, Kikuchi A: Suppression of STAT3 activity by Duplin, which is a negative regulator of the Wnt signal. J Biochem. 2006, 139: 305-314. 10.1093\/jb\/mvj033.","journal-title":"J Biochem"},{"key":"5063_CR27","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1038\/sj.onc.1209235","volume":"25","author":"R Muromoto","year":"2006","unstructured":"Muromoto R, Nakao K, Watanabe T, Sato N, Sekine Y, Sugiyama K, Oritani K, Shimoda K, Matsuda T: Physical and functional interactions between Daxx and STAT3. Oncogene. 2006, 25: 2131-2136. 10.1038\/sj.onc.1209235.","journal-title":"Oncogene"},{"key":"5063_CR28","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.bbrc.2009.07.023","volume":"387","author":"Z Wu","year":"2009","unstructured":"Wu Z, Zhang X, Yang J, Wu G, Zhang Y, Yuan Y, Jin C, Chang Z, Wang J, Yang X, He F: Nuclear protein IkappaB-zeta inhibits the activity of STAT3. Biochem Biophys Res Commun. 2009, 387: 348-352. 10.1016\/j.bbrc.2009.07.023.","journal-title":"Biochem Biophys Res Commun"},{"key":"5063_CR29","doi-asserted-by":"publisher","first-page":"10120","DOI":"10.1073\/pnas.170192197","volume":"97","author":"RG Collum","year":"2000","unstructured":"Collum RG, Brutsaert S, Lee G, Schindler C: A Stat3-interacting protein (StIP1) regulates cytokine signal transduction. Proc Natl Acad Sci. 2000, 97: 10120-10125. 10.1073\/pnas.170192197.","journal-title":"Proc Natl Acad Sci"},{"key":"5063_CR30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0968-0004(99)01384-5","volume":"24","author":"TF Smith","year":"1999","unstructured":"Smith TF, Gaitatzes C, Saxena K, Neer EJ: The WD repeat: a common architecture for diverse functions. Trends Biochem Sci. 1999, 24: 181-185. 10.1016\/S0968-0004(99)01384-5.","journal-title":"Trends Biochem Sci"},{"key":"5063_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1590\/S0001-37652001000100007","volume":"73","author":"VM Rumjanek","year":"2001","unstructured":"Rumjanek VM, Trindade GS, Wagner-Souza K, de-Oliveira MC, Marques-Santos LF, Maia RC, Capella MA: Multidrug resistance in tumour cells: characterization of the multidrug resistant cell line K562-Lucena 1. An Acad Bras Cienc. 2001, 73: 57-69. 10.1590\/S0001-37652001000100007.","journal-title":"An Acad Bras Cienc"},{"key":"5063_CR32","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ: Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008, 3: 1101-1108. 10.1038\/nprot.2008.73.","journal-title":"Nat Protoc"},{"key":"5063_CR33","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0022-1759(91)90198-O","volume":"139","author":"I Nicoletti","year":"1991","unstructured":"Nicoletti I, Migliorati G, Pagliaccil MC, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods. 1991, 139: 271-279. 10.1016\/0022-1759(91)90198-O.","journal-title":"J Immunol Methods"},{"key":"5063_CR34","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1182\/blood-2002-04-1204","volume":"15","author":"M Benekli","year":"2003","unstructured":"Benekli M, Baer MR, Baumann H, Wetzler M: Signal transducer and activator of transcription proteins in leukemias. Blood. 2003, 15: 2940-2954.","journal-title":"Blood"},{"key":"5063_CR35","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s00280-009-1109-3","volume":"65","author":"AL Mencalha","year":"2010","unstructured":"Mencalha AL, Du Rocher B, Salles D, Binato R, Abdelhay E: LLL-3, a STAT3 inhibitor, represses BCR-ABL-positive cell proliferation, activates apoptosis and improves the effects of Imatinib mesylate. Cancer Chemother Pharmacol. 2010, 65: 1039-1046. 10.1007\/s00280-009-1109-3.","journal-title":"Cancer Chemother Pharmacol"},{"key":"5063_CR36","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.canlet.2006.10.017","volume":"251","author":"DA Frank","year":"2007","unstructured":"Frank DA: STAT3 as a central mediator of neoplastic cellular transformation. Cancer Lett. 2007, 251: 199-210. 10.1016\/j.canlet.2006.10.017.","journal-title":"Cancer Lett"},{"key":"5063_CR37","doi-asserted-by":"publisher","first-page":"6132","DOI":"10.1074\/jbc.273.11.6132","volume":"273","author":"M Ichiba","year":"1998","unstructured":"Ichiba M, Nakajima K, Yamanaka Y, Kiuchi N, Hirano T: Autoregulation of the Stat3 gene through cooperation with a cAMP-responsive element-binding protein. J Biol Chem. 1998, 273: 6132-6138. 10.1074\/jbc.273.11.6132.","journal-title":"J Biol Chem"},{"key":"5063_CR38","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1038\/sj.onc.1210952","volume":"27","author":"R Tsuruma","year":"2008","unstructured":"Tsuruma R, Ohbayashi N, Kamitani S, Ikeda O, Sato N, Muromoto R, Sekine Y, Oritani K, Matsuda T: Physical and functional interactions between STAT3 and KAP1. Oncogene. 2008, 27: 3054-3059. 10.1038\/sj.onc.1210952.","journal-title":"Oncogene"},{"key":"5063_CR39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1477-5956-10-23","volume":"10","author":"S Corr\u00eaa","year":"2012","unstructured":"Corr\u00eaa S, Pizzatti L, Du Rocher B, Mencalha A, Pinto D, Abdelhay E: A comparative proteomic study identified LRPPRC and MCM7 as putative actors in imatinib mesylate cross-resistance in Lucena cell line. Proteome Sci. 2012, 10: 23-10.1186\/1477-5956-10-23.","journal-title":"Proteome Sci"},{"key":"5063_CR40","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1074\/jbc.M110445200","volume":"277","author":"NA Hawkes","year":"2002","unstructured":"Hawkes NA, Otero G, Winkler GS, Marshall N, Dahmus ME, Krappmann D, Scheidereit C, Thomas CL, Schiavo G, Erdjument-Bromage H, Tempst P, Svejstrup JQ: Purification and characterization of the human elongator complex. J Biol Chem. 2002, 277: 3047-3055. 10.1074\/jbc.M110445200.","journal-title":"J Biol Chem"},{"key":"5063_CR41","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.3109\/10428194.2010.483748","volume":"51","author":"LD Ma","year":"2010","unstructured":"Ma LD, Zhou M, Wen SH, Ni C, Jiang LJ, Fan J, Xia L: Effects of STAT3 silencing on fate of chronic myelogenous leukemia K562 cells. Leuk Lymphoma. 2010, 51: 1326-1336. 10.3109\/10428194.2010.483748.","journal-title":"Leuk Lymphoma"},{"key":"5063_CR42","doi-asserted-by":"publisher","first-page":"17635","DOI":"10.1074\/jbc.M800109200","volume":"283","author":"LYW Bourguignon","year":"2008","unstructured":"Bourguignon LYW, Peyrollier K, Xia W, Gilad E: Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells. J Biol Chem. 2008, 283: 17635-1751. 10.1074\/jbc.M800109200.","journal-title":"J Biol Chem"},{"key":"5063_CR43","doi-asserted-by":"publisher","first-page":"20965","DOI":"10.1371\/journal.pone.0020965","volume":"6","author":"X Zhang","year":"2011","unstructured":"Zhang X, Xiao W, Wang L, Tian Z, Zhang J: Deactivation of signal transducer and activator of transcription 3 reverses chemotherapeutics resistance of leukemia cells via down-regulating P-gp. PLoS One. 2011, 6: 20965-20969. 10.1371\/journal.pone.0020965.","journal-title":"PLoS One"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-866.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-14-866\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-866","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T21:42:27Z","timestamp":1468359747000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-14-866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,23]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["5063"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-14-866","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,23]]},"article-number":"866"}}